Abstract
Introduction
Since the 1960s, hormonal contraceptives have been widely used as effective
birth control in the developed world. Although they are mainly used to prevent
pregnancies, they can be used for treating other conditions such as acne,
endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal
contraceptives market was worth $6.2 billion across the seven major
pharmaceutical countries.
Scope of this research
- Analysis of the global hormonal contraceptive prescriptions from 200408,
split by geographical region, drug class, indication, and brand.
- Discussion of key commercial opportunities and threats in the US, Japan,
and five major European markets.
- In depth profiles of key current hormonal contraceptive brands and
pipeline agents with SWOT analyses and country-specific sales forecasts to
2018.
- Detailed analysis of key developer trends, strategies and portfolios
including a case study of Bayer-Schering' s Yasmin franchise.
Research and analysis highlights
Sales of hormonal contraceptives in the seven major markets accounted for 68%
of the global market value. Over the forecast period 20092018, the market is
expected to grow due to the launch of novel natural estrogen products, which
will be well received in the US in particular, and the launch of new
prescription emergency contraceptives in the EU.
The market offers opportunities for current and future market players. In
addition to indication expansions, there is the need to develop delivery
mechanisms that will increase compliance and efficacy. However, the current
market environment poses several threats to market growth such as the high
litigation pressure and the need to cut sales forces
Marketing is a key tool for companies in this market to increase sales of
their brands. Datamonitor recommends that companies should also focus on
marketing the secondary benefits of taking hormonal contraceptives, such as
the decreased risk of gynecological cancers, to increase acceptance of
contraceptives.
Key reasons to purchase this research
- Understand historical (200408) and future (20092018) hormonal
contraceptive drug market dynamics and competitive environment.
- Gain insight into the main opportunities and threats specific to the
hormonal contraceptive market.
- Evaluate the sales forecasts of marketed, generic, and key pipeline drugs
to 2018 in the US, Japan, France, Germany, Italy, Spain, and the UK.
| 
View Cart
